搜尋結果
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
CNBC· 7 日前It agreed to pay $1.3 billion in cash and another $1.7 billion in future milestone-based ...
Merck To Pay as Much as $3 Billion for Eye Treatment Startup
Bloomberg· 7 日前Have a confidential tip for our reporters? Merck & Co. restocked its cabinet of eye treatments ...
CoinFund's Seth Ginns on why the crypto downturn has spared early-stage startups
TechCrunch· 7 日前Startups haven’t been completely immune to the downturn — late-stage companies have taken the ...
Clean Energy Ventures raises $305 million to back early-stage climate startups
CNBC· 7 日前Clean energy stocks may be underperforming in the public market. The climate tech firm said ...
How Clean Energy Ventures avoided the pandemic bubble and raised a $305M fund
TechCrunch· 7 日前Instead, Clean Energy Ventures took a different approach, and it appears to be paying off. Late in 2022, Goldman and his ...
Exclusive | Homecoming Capital Backs Port Developer for Offshore Wind Projects
The Wall Street Journal· 7 日前The private-investment firm pledged $50 million to Clean Energy Terminals to finance early-stag ...